Delivery Order SPE2DB22D1106-SPE2DB24FFLG1

Award Date 9/5/24
Potential Completion Date 9/26/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,152.50 firm-fixed-price contract is for the supply of 4564934289 - ALBUKED-25 vials, a medical product. The contract has an ultimate completion date of July 10, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This is a $2,281.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ALBUKED-25 VIAL 100ML, a medical product, with a performance period through July 16, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,320.60, is for the delivery of ALBUKED-5 VIAL 250ML pharmaceutical products. It is a firm fixed-price contract with a period of performance ending on June 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ALBUKED-25 VIAL 50ML, a pharmaceutical product, with a ceiling value of $1,163.00. The contract is a firm fixed-price delivery order with a period of performance ending on May 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ALBUKED-25 VIAL 100ML products. The contract has a ceiling value of $1,368.90 and is a Firm Fixed Price delivery order. It is not set aside and has an ultimate completion date of July 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of ALBUKED-25 VIAL 100ML pharmaceutical products. The contract has a ceiling value of $2,152.50 and is a Firm Fixed Price type contract with an ultimate completion date of October 3, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this delivery order. As a large supplier...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply ALBUKED-25 VIAL 100ML pharmaceuticals. The delivery order, valued at $1,033.20, has a performance period through March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order which falls under a larger indefinite delivery contract (IDC) awarded by DLA. The IDC,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,320.60 contract is for the delivery of ALBUKED-5 VIAL 250ML medical supplies, with a completion date of July 9, 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a global pharmaceutical support...
This federal contract award is for Delivery Order 4568221629 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,281.50 firm fixed-price contract is for the supply of ALBUKED-25 VIAL 100ML medical products, with a period of performance through June 3, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,140.75 firm-fixed-price contract is for the delivery of ALBUKED-25 VIAL 100ML, a medication, with a performance period through May 2025. The contract is not set aside for any specific type of business. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFLG1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of ALBUKED-25 vials. The contract has a firm fixed price of $2,152.50 and a completion date of September 26, 2024. There is no set-aside designation mentioned. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, for providing a wide range of pharmaceutical products and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives nationwide.

Generated 12/5/24, 10:23 AM